Morie A. Gertz, MD, MACP
Morie A. Gertz, M.D., has research interests in amyloidosis and multiple myeloma. Particularly, Dr. Gertz studies relapse rates in patients with multiple myeloma and amyloidosis when being treated with novel versus traditional therapies. His focus areas include Primary Amyloidosis, stem cell transplantation in the treatment of Multiple Myeloma, Amyloidosis, and Waldenström's Macroglobulinemia.
The research findings of Dr. Gertz will lead to improved treatment for amyloidosis and multiple myeloma.
Professional highlights:
- Member, Committee on Training, American Society of Hematology, 2015-present
- Member, Hematology Board Exam Committee, American Board of Internal Medicine, 2015-present
- Waldenström Award for medical and scientific achievements in Waldenström's macroglobulinemia, 2014
- Treasurer, International Myeloma Society, 2011-2014
- Mayo Clinic Roland Seidler, Jr. Professor of the Art of Medicine Honoring Dr. Michael Brennan, 2010
- President, Mayo Staff Officers and Councilors, Mayo Clinic, 2005
Timothy Pearman, PhD
Dr. Timothy Pearman is Professor in the departments of Medical Social Sciences and Psychiatry & Behavioral Sciences at the Northwestern University Feinberg School of Medicine. He is a board certified clinical health psychologist, a Fellow of the American Academy of Clinical Health Psychology (ACHP) and Director of the Supportive Oncology program at the Robert H. Lurie Comprehensive Cancer Center.
Dr. Pearman has served on the National Institutes of Health (NIH) Health Disparities and Equity Promotion (HDEP) subcommittee, as well as the National Cancer Institute (NCI) Subcommittee G (Education). He completed a term as the APOS representative to the American College of Surgeons in 2021. He served on the National Comprehensive Cancer Network (NCCN)’s distress management expert panel. He served as the disease section leader for quality of life for the Scientific Review Committee of the Robert H. Lurie Comprehensive Cancer Center.
He is a member of the Institute for Public Health and Medicine at Northwestern University, and is a member of the Northwestern Medicine Cancer Committee. He has been a clinical associate professor in the Department of Psychiatry & Neurology at the Tulane University School of Medicine since 2000 and was the Director of the Tulane Cancer Center in New Orleans, LA from 2008-2011.
